Azimilide Reduces Emergency Department Visits and Hospitalizations in Patients With an Implantable Cardioverter-Defibrillator in a Placebo-Controlled Clinical Trial
- 23 September 2008
- journal article
- research article
- Published by Elsevier BV in Journal of the American College of Cardiology
- Vol. 52 (13), 1076-1083
- https://doi.org/10.1016/j.jacc.2008.05.055
Abstract
No abstract availableKeywords
This publication has 24 references indexed in Scilit:
- Electrical storm in patients with an implantable defibrillator: incidence, features, and preventive therapy: insights from a randomized trialEuropean Heart Journal, 2006
- Impact of implantable cardioverter defibrillators on survival and recurrent hospitalization in advanced heart failureAmerican Heart Journal, 2005
- Implantable Cardioverter-Defibrillators, Induced Anxiety, and Quality of LifeMayo Clinic Proceedings, 2005
- Placebo-Controlled, Randomized Clinical Trial of Azimilide for Prevention of Ventricular Tachyarrhythmias in Patients With an Implantable Cardioverter DefibrillatorCirculation, 2004
- Prevalence, Predictors, and Mortality Significance of the Causative Arrhythmia in Patients with Electrical StormJournal of Cardiovascular Electrophysiology, 2004
- Come See the Softer Side of Clinical Outcomes:Journal of Cardiovascular Electrophysiology, 2004
- Prophylactic Implantation of a Defibrillator in Patients with Myocardial Infarction and Reduced Ejection FractionNew England Journal of Medicine, 2002
- Semiparametric Regression for the Mean and Rate Functions of Recurrent EventsJournal of the Royal Statistical Society Series B: Statistical Methodology, 2000
- A Randomized Study of the Prevention of Sudden Death in Patients with Coronary Artery DiseaseNew England Journal of Medicine, 1999
- Cox's Regression Model for Counting Processes: A Large Sample StudyThe Annals of Statistics, 1982